Last updated: 2026-10-11 07:12:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Polyrizon Ltd. (PLRZ) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $9.17, with a market capitalization of $21.83M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.88 to $18.20. This page covers its latest market performance, valuation, price trends and company information.
$21.83M | |
$8.38 | |
$7,200.00 | |
$2.88 | |
$8.87 | |
39.96K | |
61.33K | |
-- | |
$18.20 | |
$2.88 | |
-- | |
-- |
Polyrizon Ltd. (PLRZ) last closed at $8.87 as of 2026-10-09 23:31:00, unchanged from the previous close of $8.87.
During the latest regular trading session, PLRZ traded between $2.88 and $7,200.00, with a volume of 39.96K shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, Polyrizon Ltd. (PLRZ) moved from $10.32 to $9.17, representing a decline of 11.12% ($1.15).
The stock traded between $8.22 and $10.87 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 19.60 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 41.1%
PLRZ is currently trading at $9.17, placing it 41.1% of the way from its 52-week low of $2.88 to its 52-week high of $18.20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.
| Employees | 1 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Polyrizon Ltd. (PLRZ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.